Kosenko E, Kaminsky Y, Grau E, et al
YesMedicare Can Now Cover Foundayo for Weight Loss As of July 1, 2026, Medicare covers Foundayo for weight loss through the new Medicare GLP-1 Bridge a flat $50/month , covering all Foundayo formulations , for Part D beneficiaries who meet the BMI-based eligibility criteria
However, with the right interventionsincluding evidence-based oral care solutions like MetaQil and Lubricity it is possible to significantly reduce the impact of polypharmacy on both oral health and quality of life
Weight loss achieved through Zepbound therapy may ultimately improve reflux symptoms over time, as excess abdominal weight is a major risk factor for GERD
There are multiple FDA-approved and affordable prescription options available, including alternatives for those no longer able to access compounded semaglutide or tirzepatide
Patients concerned about GLP-1 treatment should work directly with their healthcare providers to address specific issues